RecruitingPHASE1, PHASE2NCT07266116

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients

Studying AL amyloidosis

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Intervention: TQB2934 injection(drug)
Enrollment: 70 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2025 – 2029

Study locations (23)

Peking University First Hospital, Beijing, Beijing Municipality, China
Peking University People's Hospital, Beijing, Beijing Municipality, China
Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, Chongqing Municipality, China
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Guangzhou First Municipal People's Hospital, Guangzhou, Guangdong, China
Peking University ShenZhen Hospital, Shenzhen, Guangdong, China
The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
Affiliated Hospital of Hebei University, Baoding, Hebei, China
The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
Anyang People's Hospital, Anyang, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Xiangya Hospital of Central South University, Changsha, Hunan, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
The first hospital of Jilin University, Changchun, Jilin, China
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
+8 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07266116 on ClinicalTrials.gov

Other trials for AL amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for AL amyloidosis →

← Back to all trials